Home > Healthcare > Pharmaceuticals > Finished Drug Form > Leuprolide Acetate Market

Leuprolide Acetate Market Size

Report ID: GMI5432
Published Date: Feb 2023
Report Format: PDF

Download Free Sample

Leuprolide Acetate Market Size

Leuprolide Acetate Market size valuation was recorded at over USD 2 billion in 2022 and is estimated to grow at a 6% CAGR between 2023 and 2032 driven by soaring awareness regarding the benefits of leuprolide acetate injections.

To get key market trends

Download Free Sample

Rising incidences of cancer globally are set to fuel market progress. For instance, Europe constitutes nearly a quarter of all cancer diagnoses in the world. According to estimations, the four most prevalent cancer types in Europe account for over 50% of all cancer diagnoses, with breast cancer accounting for 13.1%, colorectal cancer for 12.9%, lung cancer for approximately 11.8%, and prostate cancer for nearly 11.7%. This is propelling the demand for leuprolide acetate medications for cancer treatment in the coming years.

Furthermore, the growing female population base suffering from endometriosis is also promoting product use. According to an OASH report, endometriosis affects approximately 176 million women worldwide and 11% of American women between the ages of 15 to 44. A study based on leuprolide acetate’s impact on endometriosis patients post hysterectomy and BSO concluded that these drugs aided in complete preoperative pain relief after the completion of procedures.

Leuprolide Acetate Market Report Attributes
Report Attribute	Details
Base Year:	2022
Leuprolide Acetate Market Size in 2022:	USD 2 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	6%
2032 Value Projection:	USD 3.5 Billion
Historical Data for:	2018 to 2022
No. of Pages:	320
Tables, Charts & Figures:	363
Segments covered:	Product Form, Application, Route of Administration, Distribution Channel, and Region
Growth Drivers:	Rising incidences of cancer worldwide Increasing drug-related research and development activities Growing female population base suffering from endometriosis Upsurge in awareness regarding precocious puberty
Pitfalls & Challenges:	High costs associated with leuprolide acetate drugs Adverse drug price control policies

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for leuprolide acetate was valued at more than USD 2 billion in 2022 and is set to progress at a 6% CAGR between 2023 and 2032 owing to the growing female population suffering from endometriosis and cancer as well as the soaring awareness regarding the benefits of leuprolide acetate injections.

The cancer application segment held more than 25% revenue share in 2022 and is projected to observe notable growth through 2032 due to the global rise in cancer cases which is increasing the demand for leuprolide acetate drugs for treatment.

The pre-filled syringes segment surpassed USD 910 million in revenue in 2022 as a result of rising consumer demand due to reduced patient risk and growing knowledge pertaining to the advantages of pre-filled syringes.

North America leuprolide acetate market held more than 39% market share in 2022 and is anticipated to record sizable progress over 2023-2032 on account of the favorable landscape for product approval from regulatory bodies, such as the U.S. FDA, in the region.